<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Crystallogr D Struct Biol</journal-id><journal-id journal-id-type="iso-abbrev">Acta Crystallogr D Struct Biol</journal-id><journal-id journal-id-type="publisher-id">Acta Cryst. D</journal-id><journal-title-group><journal-title>Acta Crystallographica. Section D, Structural Biology</journal-title></journal-title-group><issn pub-type="epub">2059-7983</issn><publisher><publisher-name>International Union of Crystallography</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6130466</article-id><article-id pub-id-type="publisher-id">ud5004</article-id><article-id pub-id-type="doi">10.1107/S2059798318008318</article-id><article-id pub-id-type="coden">ACSDAD</article-id><article-id pub-id-type="pii">S2059798318008318</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Papers</subject></subj-group></article-categories><title-group><article-title>Crystal structure of the post-fusion core of the <italic>Human coronavirus 229E</italic> spike protein at 1.86&#x02005;&#x000c5; resolution</article-title><alt-title>Post-fusion core of the <italic>Human coronavirus 229E</italic> spike protein</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="b">b</xref><xref ref-type="aff" rid="c">c</xref><xref ref-type="aff" rid="d">d</xref></contrib><contrib contrib-type="author"><name><surname>Meng</surname><given-names>Bing</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Jiangchao</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="b">b</xref><xref ref-type="aff" rid="c">c</xref><xref ref-type="aff" rid="d">d</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Ian A.</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="e">e</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5389-3859</contrib-id><name><surname>Yang</surname><given-names>Bei</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><aff id="a">
<label>a</label>Shanghai Institute for Advanced Immunochemical Studies, <institution>ShanghaiTech University</institution>, 393 Middle Huaxia Road, Shanghai 201210, <country>People&#x02019;s Republic of China</country>
</aff><aff id="b">
<label>b</label>School of Life Science and Technology, <institution>ShanghaiTech University</institution>, 393 Middle Huaxia Road, Shanghai 201210, <country>People&#x02019;s Republic of China</country>
</aff><aff id="c">
<label>c</label>Shanghai Institute of Biochemistry and Cell Biology, <institution>Chinese Academy of Sciences</institution>, 320 Yueyang Road, Shanghai 200031, <country>People&#x02019;s Republic of China</country>
</aff><aff id="d">
<label>d</label>
<institution>University of Chinese Academy of Sciences</institution>, 19A Yuquan Road, Beijing 100049, <country>People&#x02019;s Republic of China</country>
</aff><aff id="e">
<label>e</label>Department of Integrative Structural and Computational Biology, <institution>The Scripps Research Institute</institution>, 10550 North Torrey Pines Road, BCC206, La Jolla, CA 92037, <country>USA</country>
</aff></contrib-group><author-notes><corresp id="cor">Correspondence e-mail: <email>wilson@scripps.edu</email>, <email>yangbei@shanghaitech.edu.cn</email></corresp></author-notes><pub-date pub-type="collection"><day>01</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>03</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>03</day><month>9</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>74</volume><issue>Pt 9</issue><issue-id pub-id-type="publisher-id">d180900</issue-id><fpage>841</fpage><lpage>851</lpage><history><date date-type="received"><day>07</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>05</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; Yan et al. 2018</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/uk/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original authors and source are cited.</license-p><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/2.0/uk/</ali:license_ref></license></permissions><self-uri xlink:href="https://doi.org/10.1107/S2059798318008318">A full version of this article is available from Crystallography Journals Online.</self-uri><abstract abstract-type="toc"><p>The complete post-fusion core structure of the <italic>Human coronavirus 229E</italic> spike protein was determined at 1.86&#x02005;&#x000c5; resolution. Comparison of the interactions between heptad repeats HR1 and HR2 in different human coronaviruses reveals some differences, which should be taken into consideration when designing pan-coronavirus HR2-mimicking inhibitors that target HR1.</p></abstract><abstract><p>
<italic>Human coronavirus 229E</italic> (HCoV-229E) usually causes mild upper respiratory infections in heathy adults, but may lead to severe complications or mortality in individuals with weakened immune systems. Virus entry of HCoV-229E is mediated by its spike (S) protein, where the S1 domain facilitates attachment to host cells and the S2 domain is involved in subsequent fusion of the virus and host membranes. During the fusion process, two heptad repeats, HR1 and HR2, in the S2 domain assemble into a six-helix membrane-fusion structure termed the fusion core. Here, the complete fusion-core structure of HCoV-229E has been determined at 1.86&#x02005;&#x000c5; resolution, representing the most complete post-fusion conformation thus far among published human alphacoronavirus (&#x003b1;-HCoV) fusion-core structures. The overall structure of the HCoV-229E fusion core is similar to those of SARS, MERS and HCoV-NL63, but the packing of its 3HR1 core differs from those of SARS and MERS in that it contains more noncanonical &#x02018;x&#x02019; and &#x02018;da&#x02019; layers. Side-by-side electrostatic surface comparisons reveal that the electrostatic surface potentials are opposite in &#x003b1;-HCoVs and &#x003b2;-HCoVs at certain positions and that the HCoV-229E surface also appears to be the most hydrophobic among the various HCoVs. In addition to the highly conserved hydrophobic interactions between HR1 and HR2, some polar and electrostatic interactions are also well preserved across different HCoVs. This study adds to the structural profiling of HCoVs to aid in the structure-based design of pan-coronavirus small molecules or peptides to inhibit viral fusion.</p></abstract><kwd-group><kwd>coronavirus</kwd><kwd>HCoV-229E</kwd><kwd>spike protein</kwd><kwd>post-fusion core</kwd><kwd>X-ray structure</kwd><kwd>SARS</kwd><kwd>MERS</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>31600619</award-id><principal-award-recipient>Bei Yang</principal-award-recipient></award-group><award-group><funding-source>Science and Technology Commission of Shanghai Municipality</funding-source><award-id>16PJ1407500</award-id><principal-award-recipient>Bei Yang</principal-award-recipient></award-group><funding-statement>This work was funded by <funding-source>National Natural Science Foundation of China</funding-source> grant <award-id>31600619</award-id> to Bei Yang. <funding-source>Science and Technology Commission of Shanghai Municipality</funding-source> grant <award-id>16PJ1407500</award-id> to Bei Yang. </funding-statement></funding-group><counts><page-count count="11"/></counts></article-meta></front><body><sec id="sec1"><label>1.</label><title>Introduction &#x000a0; </title><p>Coronaviruses (CoVs) are enveloped, positive-sense, single-stranded RNA viruses that generally cause upper respiratory and enteric infections in mammals and birds (Enjuanes <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb13"> &#x025b8;</xref>; Perlman &#x00026; Netland, 2009<xref ref-type="bibr" rid="bb46"> &#x025b8;</xref>). To date, six different strains of CoVs have been found to infect humans (hereafter referred to as HCoVs), and these include <italic>Severe acute respiratory syndrome-related coronavirus</italic> (SARS), <italic>Middle East respiratory syndrome-related coronavirus</italic> (MERS), <italic>Human coronavirus HKU1</italic> (HCoV-HKU1), <italic>Human coronavirus OC43</italic> (HCoV-OC43), <italic>Human coronavirus 229E</italic> (HCoV-229E) and <italic>Human coronavirus NL63</italic> (HCoV-NL63) (de Wilde <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb55"> &#x025b8;</xref>; Perlman &#x00026; Netland, 2009<xref ref-type="bibr" rid="bb46"> &#x025b8;</xref>). Of these HCoVs, SARS (Marra <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb37"> &#x025b8;</xref>; Ksiazek <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb30"> &#x025b8;</xref>; Peiris, Lai <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb44"> &#x025b8;</xref>; Rota <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb47"> &#x025b8;</xref>) and MERS (de Groot <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb19"> &#x025b8;</xref>; Zaki <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb64"> &#x025b8;</xref>) are notorious for their high mortality rates [10% for SARS (Peiris, Yuen <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb45"> &#x025b8;</xref>; Stadler <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb49"> &#x025b8;</xref>) and 35% for MERS (World Health Organization, 2016<xref ref-type="bibr" rid="bb54"> &#x025b8;</xref>)] and pandemic potential. HCoV-229E, on the other hand, is endemic and is frequently associated with respiratory diseases ranging from the common cold to atypical pneumonia (van der Hoek, 2007<xref ref-type="bibr" rid="bb24"> &#x025b8;</xref>). In healthy adults, HCoV-229E infection usually causes mild symptoms, including headache, cough, fever and rhinitis (Greenberg, 2016<xref ref-type="bibr" rid="bb18"> &#x025b8;</xref>), but can lead to compromised productivity in infected individuals and result in a large impact on the economy. Moreover, HCoV-229E infection can result in severe or even lethal outcomes in infants, young children, seniors and those with weakened immune systems (Forgie &#x00026; Marrie, 2009<xref ref-type="bibr" rid="bb14"> &#x025b8;</xref>; Jartti <italic>et al.</italic>, 2011<xref ref-type="bibr" rid="bb27"> &#x025b8;</xref>). Therefore, it is important to investigate the structure and function of HCoV-229E to aid in the development of preventative or therapeutic strategies.</p><p>As enveloped viruses, CoVs deliver their viral genomes into the host cytoplasm by fusing the viral membrane with either the host cell or endosome membrane (Belouzard <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb5"> &#x025b8;</xref>; Hulswit <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb26"> &#x025b8;</xref>). The spike glycoprotein (S) is an &#x0223c;500&#x02005;kDa homotrimer on the envelope surface of CoVs that plays a fundamental role in cell entry, including receptor binding and membrane fusion (Li, 2016<xref ref-type="bibr" rid="bb32"> &#x025b8;</xref>). By analogy to other class I viral fusion proteins, such as influenza virus haem&#x000ad;agglutinin (Wilson <italic>et al.</italic>, 1981<xref ref-type="bibr" rid="bb56"> &#x025b8;</xref>) or the Env protein of HIV-1 (Julien <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb28"> &#x025b8;</xref>; Lyumkis <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb36"> &#x025b8;</xref>), the S protein of CoVs can be roughly divided into two structural and functional domains: an N-terminal S1 domain for engagement with cellular receptors and a C-terminal S2 domain for membrane fusion (Belouzard <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb5"> &#x025b8;</xref>; Li, 2016<xref ref-type="bibr" rid="bb32"> &#x025b8;</xref>). The S2 domain contains a fusion peptide (FP), two heptad repeats (HRs) and a transmembrane helix (TM), arranged as FP&#x02013;HR1&#x02013;HR2&#x02013;TM (Liu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb33"> &#x025b8;</xref>).</p><p>CoV S proteins are synthesized as a single polypeptide chain, and a two-step proteolysis of the S protein prior to viral entry is pivotal for viral&#x02013;host membrane fusion (Belouzard <italic>et al.</italic>, 2009<xref ref-type="bibr" rid="bb4"> &#x025b8;</xref>; Millet &#x00026; Whittaker, 2014<xref ref-type="bibr" rid="bb41"> &#x025b8;</xref>; Park <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb43"> &#x025b8;</xref>). Specifically, proteolytic cleavage at the S1&#x02013;S2 domain junction removes the structural constraint of S1 on S2 (Li, 2016<xref ref-type="bibr" rid="bb32"> &#x025b8;</xref>; Belouzard <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb5"> &#x025b8;</xref>; Millet &#x00026; Whittaker, 2015<xref ref-type="bibr" rid="bb42"> &#x025b8;</xref>), a process in which binding of the CoV S1 domain to its cognate receptor may also contribute (Kirchdoerfer <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb29"> &#x025b8;</xref>; Yuan <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb63"> &#x025b8;</xref>; Zelus <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb65"> &#x025b8;</xref>; Matsuyama &#x00026; Taguchi, 2002<xref ref-type="bibr" rid="bb38"> &#x025b8;</xref>). At the same time, cleavage at an additional S2&#x02032; site also helps to untether the fusion peptide (FP; Li, 2016<xref ref-type="bibr" rid="bb32"> &#x025b8;</xref>; Millet &#x00026; Whittaker, 2015<xref ref-type="bibr" rid="bb42"> &#x025b8;</xref>; Belouzard <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb5"> &#x025b8;</xref>). Following this two-step cleavage, the otherwise buried hydrophobic FP becomes exposed and available to insert into the host cell membrane (Yao <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb60"> &#x025b8;</xref>). Subsequent conformational rearrangements within S2 result in the formation of the 3HR1&#x02013;3HR2 six-helical bundle, thus bringing viral and cellular membranes into close prox&#x000ad;imity and facilitating membrane fusion (Baquero <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb3"> &#x025b8;</xref>; Heald-Sargent &#x00026; Gallagher, 2012<xref ref-type="bibr" rid="bb23"> &#x025b8;</xref>).</p><p>As illustrated previously, the six-helical bundles from SARS, MERS and HCoV-NL63 feature an extended triple-helical coiled coil (HR1) surrounded by three antiparallel HR2 &#x003b1;-helices (Supekar <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb51"> &#x025b8;</xref>; Xu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb59"> &#x025b8;</xref>; Duquerroy <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb11"> &#x025b8;</xref>; Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>; Gao <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb16"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>). Such a conformation represents the post-fusion state of CoV spike proteins and is known as the fusion-core structure. More recently, the metastable pre-fusion states of <italic>Mouse hepatitis virus</italic> (MHV), HCoV-HKU1, HCoV-NL63, SARS and MERS have also been determined to high resolution by cryo-EM (Walls, Tortorici, Bosch <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb54"> &#x025b8;</xref>; Kirchdoerfer <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb29"> &#x025b8;</xref>; Walls, Tortorici, Frenz <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb54"> &#x025b8;</xref>; Gui <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb20"> &#x025b8;</xref>; Yuan <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb63"> &#x025b8;</xref>). In the pre-fusion state, the S1 domains of CoVs all reside above the trimeric S2 stalk, thereby exerting structural constraints on S2 (Walls, Tortorici, Bosch <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb52"> &#x025b8;</xref>; Walls, Tortorici, Frenz <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb53"> &#x025b8;</xref>; Kirchdoerfer <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb29"> &#x025b8;</xref>; Gui <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb20"> &#x025b8;</xref>; Yuan <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb63"> &#x025b8;</xref>). In contrast to their extended helical conformations in the post-fusion state (Xu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb59"> &#x025b8;</xref>; Gao <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb16"> &#x025b8;</xref>; Duquerroy <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb11"> &#x025b8;</xref>; Supekar <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb51"> &#x025b8;</xref>; Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>), the HR1 motifs within S2 from HCoVs form several shorter helices in their pre-fusion state (Yuan <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb63"> &#x025b8;</xref>; Walls, Tortorici, Frenz <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb53"> &#x025b8;</xref>; Gui <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb20"> &#x025b8;</xref>). Together, these snapshots of the pre-fusion and post-fusion states of S proteins further consolidate the prevailing paradigm on CoV membrane fusion and enhance our knowledge about this complex membrane-fusion apparatus.</p><p>Owing to its pivotal role in the host entry of CoVs, the spike protein has been a focus of anti-HCoV drug development. To date, a handful of viral inhibitors that target the spike proteins of SARS and MERS have been reported (Hu <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb25"> &#x025b8;</xref>; Han <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb22"> &#x025b8;</xref>; Yi <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb62"> &#x025b8;</xref>; Bosch <italic>et al.</italic> 2004<xref ref-type="bibr" rid="bb6"> &#x025b8;</xref>; Liu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb33"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>, 2015<xref ref-type="bibr" rid="bb35"> &#x025b8;</xref>; Gao <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb16"> &#x025b8;</xref>; Channappanavar <italic>et al.</italic>, 2015<xref ref-type="bibr" rid="bb7"> &#x025b8;</xref>). A subgroup of these inhibitors specifically target the interaction between the S1 domain of the SARS spike protein and its corresponding host receptors (Hu <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb25"> &#x025b8;</xref>; Han <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb22"> &#x025b8;</xref>). The remainder of these inhibitors target HR1s in the S2 domain of SARS and MERS by mimicking the corresponding HR2s, thereby inhibiting formation of the 3HR1&#x02013;3HR2 helical bundle (Bosch <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb6"> &#x025b8;</xref>; Liu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb33"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>, 2015<xref ref-type="bibr" rid="bb35"> &#x025b8;</xref>; Gao <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb16"> &#x025b8;</xref>; Channappanavar <italic>et al.</italic>, 2015<xref ref-type="bibr" rid="bb7"> &#x025b8;</xref>). Both groups of inhibitors are effective against specific HCoVs, at least <italic>in vitro</italic>. Nevertheless, the hypervariable nature of the S1 domain and the highly conserved features of the S2 domain render the latter a more suitable target for the development of pan-CoV inhibitors. As CoVs are rapidly evolving (Forni <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb15"> &#x025b8;</xref>), pandemic outbreaks of newly emerging HCoVs become possible when zoonotic CoVs are able to accumulate sufficient mutations to cross the species barrier (Ge <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb17"> &#x025b8;</xref>; Menachery <italic>et al.</italic>, 2015<xref ref-type="bibr" rid="bb39"> &#x025b8;</xref>, 2016<xref ref-type="bibr" rid="bb40"> &#x025b8;</xref>). Thus, a broad-spectrum anti-HCoV drug or vaccine would be more effective than a specific one. To this end, structural profiling of the evolutionarily conserved S2 domain, especially the 3HR1&#x02013;3HR2 six-helical bundle that drives the membrane-fusion process, would undoubtedly provide valuable information to help in the design of such a broad-spectrum anti-HCoV HR2 mimic.</p><p>Of the six HCoVs, HCoV-NL63 and HCoV-229E belong to the alphacoronavirus (&#x003b1;-CoV) family, while the other four HCoVs are classified as betacoronaviruses (&#x003b2;-CoVs) (Woo <italic>et al.</italic>, 2009<xref ref-type="bibr" rid="bb58"> &#x025b8;</xref>). Among them, HCoV-229E was the first to be identified (Hamre &#x00026; Procknow, 1966<xref ref-type="bibr" rid="bb21"> &#x025b8;</xref>). However, its spike protein has been the least structurally studied. The host receptor of HCoV-229E was revealed to be human aminopeptidase N (APN) more than two decades ago (Yeager <italic>et al.</italic>, 1992<xref ref-type="bibr" rid="bb61"> &#x025b8;</xref>). Nevertheless, structural elucidation of the interaction between HCoV-229E and APN was only revealed very recently (Wong <italic>et al.</italic>, 2017<xref ref-type="bibr" rid="bb57"> &#x025b8;</xref>). More recently, a crystal structure of the HCoV-229E fusion core (HR1 residues 788&#x02013;838 and HR2 residues 1060&#x02013;1097) was reported at 2.45&#x02005;&#x000c5; resolution (Zhang <italic>et al.</italic>, 2018<xref ref-type="bibr" rid="bb66"> &#x025b8;</xref>) while we were preparing this manuscript. Here, we present a more complete fusion-core structure of HCoV-229E at 1.86&#x02005;&#x000c5; resolution (HR1 residues 785&#x02013;873 and HR2 residues 1052&#x02013;1105) with an eight-turn longer HR1 helix and at higher resolution. The fusion-core structure of HCoV-229E is similar overall to those of SARS, MERS and HCoV-NL63. Nevertheless, since HCoV-229E has a longer HR1 and HR2, the packing of its hydrophobic core and the buried interface between HR1 and HR2 differ from those in SARS and MERS (Supekar <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb51"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>; Xu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb59"> &#x025b8;</xref>; Duquerroy <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb11"> &#x025b8;</xref>; Gao <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb16"> &#x025b8;</xref>) and are more similar to those in HCoV-NL63, another human &#x003b1;-CoV (Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>). Structural studies of the HCoV spike protein may be used to develop effective vaccines and drugs against HCoVs. We thus anticipate that our structure and the recently solved fusion-core structure of HCoV-229E, along with those of SARS, MERS and NL63, may serve as a template for the design of structure-based pan-coronavirus small molecules or peptides to inhibit viral fusion.</p></sec><sec id="sec2"><label>2.</label><title>Materials and methods &#x000a0; </title><sec id="sec2.1"><label>2.1.</label><title>Plasmid construction &#x000a0; </title><p>To express the HCoV-229E fusion core, the coding sequences for HR1 (residues 785&#x02013;873) and HR2 (residues 1052&#x02013;1105) were connected <italic>via</italic> a short linker (encoding L6; SGGRGG) by overlapping PCR. The resulting sequence HR1-L6-HR2 was then subcloned into the pET-28a vector with an N-terminal in-frame SUMO tag. The final construct thus contains an N-terminal His<sub>6</sub> tag followed by the SUMO domain including the recognition sequence for Ulp1 and the coding sequence for HR1-L6-HR2.</p></sec><sec id="sec2.2"><label>2.2.</label><title>Protein production and purification &#x000a0; </title><p>For protein production, the pET-28-SUMO-HR1-L6-HR2 plasmid was transformed into <italic>Escherichia coli</italic> strain BL21 (DE3) competent cells. A single colony was inoculated into 5&#x02005;ml Luria&#x02013;Bertani (LB) medium containing 100&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin (AMRESCO) and incubated overnight at 37&#x000b0;C. The overnight culture was then seeded into 2&#x02005;l fresh LB medium and cultured at 37&#x000b0;C until the OD<sub>600</sub> (optical density at 600&#x02005;nm) reached 0.6. Target protein overexpression was then induced with 1&#x02005;m<italic>M</italic> isopropyl &#x003b2;-<sc>d</sc>-1-thiogalactopyranoside (IPTG; AMRESCO) at 16&#x000b0;C for 16&#x02005;h. After harvesting <italic>via</italic> centrifugation at 16&#x02005;000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> for 30&#x02005;min, the cell debris was resuspended in lysis buffer (50&#x02005;m<italic>M</italic> Tris&#x02013;HCl pH 7.5, 300&#x02005;m<italic>M</italic> NaCl) supplemented with phenylmethylsulfonyl fluoride (PMSF; Biovision) and lysed using a sonicator (Thermo Fisher Scientific). The cell lysate was then centrifuged at 70&#x02005;000<italic>g</italic> for 20&#x02005;min at 4&#x000b0;C. The supernatant was collected and loaded onto TALON metal-affinity resin (Clontech). After extensive washing, the HR1-L6-HR2 protein of interest was eluted with lysis buffer supplemented with 500&#x02005;m<italic>M</italic> imidazole. The fractions eluted from the TALON column were then dialyzed against dialysis buffer (20&#x02005;m<italic>M</italic> Tris&#x02013;HCl pH 8.0, 5&#x02005;m<italic>M</italic> &#x003b2;-mercaptoethanol, 150&#x02005;m<italic>M</italic> NaCl) overnight at 4&#x000b0;C and then processed with Ulp1 [at a 1:100(<italic>w</italic>:<italic>w</italic>) ratio] to remove the SUMO tag from HR1-L6-HR2. Finally, the cleaved product was applied onto a Superdex 75 gel-filtration column (GE Healthcare). Fractions containing a homogeneous HR1-L6-HR2 trimer were collected and concentrated by ultrafiltration using Amicon Ultra-4 10&#x02005;kDa centrifugal filter units (Millipore). All chemicals were from Sigma&#x02013;Aldrich unless otherwise specified.</p></sec><sec id="sec2.3"><label>2.3.</label><title>Crystallization, data collection and structure determination &#x000a0; </title><p>The HR1-L6-HR2 fusion protein was crystallized at 20&#x000b0;C using the hanging-drop vapour-diffusion method. Crystals were grown on a siliconized cover slip by equilibrating a mixture consisting of 1&#x02005;&#x000b5;l protein solution (8&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> HR1-L6-HR2 trimer in 20&#x02005;m<italic>M</italic> Tris&#x02013;HCl pH 8.0, 150&#x02005;m<italic>M</italic> NaCl) and 1&#x02005;&#x000b5;l reservoir solution (0.03&#x02005;<italic>M</italic> citric acid, 0.07&#x02005;<italic>M</italic> bis-tris propane pH 7.6, 20% PEG 3350) against 400&#x02005;&#x000b5;l reservoir solution. Single crystals grew after one week and were flash-cooled in liquid nitrogen for data collection after adding 20% glycerol as a cryoprotectant.</p><p>Diffraction data were collected on beamline BL17U1 of the Shanghai Synchrotron Radiation Facility (SSRF) using a wavelength of 0.9795&#x02005;&#x000c5; and an ADSC Q315r CCD detector. 360 images were recorded at a distance of 250&#x02005;mm with a 1&#x000b0; oscillation angle and an exposure time of 1.0&#x02005;s. Raw data were indexed and processed using <italic>HKL</italic>-3000 in space group <italic>R</italic>32:<italic>H</italic>. Molecular replacement was performed with <italic>Phaser</italic> in <italic>PHENIX</italic> (Adams <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb1"> &#x025b8;</xref>) using the HCoV-NL63 fusion-core structure (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=2ieq">2ieq</ext-link>; Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>) as a search model. The initial model was further improved by cycles of manual building and refinement using <italic>Coot</italic> (Emsley <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb12"> &#x025b8;</xref>) and <italic>PHENIX</italic> (Adams <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb1"> &#x025b8;</xref>). Torsion-angle NCS restraints and TLS groups were used during refinement. The quality of the final model was analysed with <italic>MolProbity</italic> (Chen <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb8"> &#x025b8;</xref>). Data-collection and refinement statistics are shown in Table 1<xref ref-type="table" rid="table1"> &#x025b8;</xref>. Atomic coordinates and structure factors have been deposited in the Protein Data Bank (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=5yl9">5yl9</ext-link>). Figures were prepared with <italic>PyMOL</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org">http://www.pymol.org</ext-link>). Electrostatic calculations were performed with <italic>PDB</italic>2<italic>PQR</italic> (Dolinsky <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb9"> &#x025b8;</xref>). The volumes of cavities and pockets were calculated with the <italic>CASTp</italic> 3.0 online server (Dundas <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb10"> &#x025b8;</xref>). Pitch values were calculated with <italic>TWISTER</italic> (Strelkov &#x00026; Burkhard, 2002<xref ref-type="bibr" rid="bb50"> &#x025b8;</xref>).</p></sec></sec><sec id="sec3"><label>3.</label><title>Results &#x000a0; </title><sec id="sec3.1"><label>3.1.</label><title>Overall architecture of the HCoV-229E fusion core &#x000a0; </title><p>The HR1 (residues 785&#x02013;873) and HR2 (residues 1052&#x02013;1105) regions of HCoV-229E were connected <italic>via</italic> a six-amino-acid linker (L6; SGGRGG), thereby generating an HR1-L6-HR2 fusion protein (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>a</italic>). Similar linkers have been utilized in structural studies of MHV and HCoV-NL63 fusion cores and were found not to affect the intrinsic interaction (or packing) between HR1 and HR2 (Xu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb59"> &#x025b8;</xref>; Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>). The HR1-L6-HR2 construct crystallized in space group <italic>R</italic>32:<italic>H</italic>, with unit-cell parameters <italic>a</italic>&#x000a0;=&#x000a0;<italic>b</italic> = 46.9, <italic>c</italic> = 402.1&#x02005;&#x000c5; and one molecule per asymmetric unit (Table 1<xref ref-type="table" rid="table1"> &#x025b8;</xref>). The structure was solved by molecular replacement using the crystal structure of the HCoV-NL63 fusion core (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=2ieq">2ieq</ext-link>) as the search model, and was refined to a final resolution of 1.86&#x02005;&#x000c5; with an <italic>R</italic>
<sub>cryst</sub> of 18.4% and an <italic>R</italic>
<sub>free</sub> of 20.6% (Table 1<xref ref-type="table" rid="table1"> &#x025b8;</xref>).</p><p>HR1 of HCoV-229E forms a 24-turn &#x003b1;-helix, while HR2 of HCoV-229E adopts a mixed conformation: residues 1067&#x02013;1098 fold into a nine-turn &#x003b1;-helix, while residues 1052&#x02013;1066 and 1099&#x02013;1105 on either side of the helix adopt an extended conformation (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>b</italic>). The HR1 regions of three HR1-L6-HR2 molecules are arranged around the crystallographic threefold symmetry axis and form the central hydrophobic core (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>c</italic>). The three companion HR2 regions pack on the outside into the hydrophobic grooves that are formed between adjacent HR1 helices (Figs. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>c</italic> and 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>d</italic>) in an antiparallel manner, resulting in a six-helical bundle structure with dimensions of &#x0223c;128&#x02005;&#x000c5; in length and 32&#x02005;&#x000c5; in diameter with a left-handed supercoil (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>c</italic>). Such a structure is typical for the CoV fusion core and represents the post-fusion state of the HCoV-229E spike protein. As our structure is at higher resolution and the HR1 and HR2 motifs are more complete than in Zhang <italic>et al.</italic> (2018<xref ref-type="bibr" rid="bb66"> &#x025b8;</xref>), we therefore used our HCoV-229E structure in the following comparisons of different HCoVs.</p></sec><sec id="sec3.2"><label>3.2.</label><title>Hydrophobic core packing of the long HR1 from HCoV-229E &#x000a0; </title><p>Sequence alignment of HCoVs indicates that a 14-amino-acid insertion arises in the HR1 regions of HCoV-NL63 and HCoV-229E (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>f</italic>) that would make the HR1 helix of HCoV-229E four turns (two heptad repeats) longer than those of MERS and SARS (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>e</italic>; insertion highlighted in red). To compensate for their longer HR1 regions, the HR2 region of HCoV-229E or HCoV-NL63 also contains a 14-residue insertion (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>g</italic>) that contributes to a longer HR2 helix (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>e</italic>; insertion highlighted in yellow).</p><p>The 24-turn &#x003b1;-helix of HCoV-229E HR1 is the longest among all HCoV fusion-core structures published thus far (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>). 26 hydrophobic residues as well as three polar residues (Gln791, Thr819 and Gln840) from each HR1 line the coiled-coil interface and pack in layers to form the hydrophobic 3HR1 core of HCoV-229E (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>, first panel). Besides the canonical &#x02018;a&#x02019; and &#x02018;d&#x02019; layers, which are a feature of heptad repeats, Zheng and coworkers introduced the concept of &#x02018;x&#x02019; and &#x02018;da&#x02019; (or &#x02018;y&#x02019;) layers to illustrate the noncanonical packing modes observed in the structure of the HCoV-NL63 fusion core (Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>). Such &#x02018;x&#x02019; and &#x02018;da&#x02019; packing modes are also observed here for the 3HR1 core of HCoV-229E (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>, first panel). Interestingly, the four additional turns that are unique to &#x003b1;-HCoVs (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>f</italic>) all adopt noncanonical packing geometry, with &#x02018;d/a&#x02019; layers alternating with &#x02018;x&#x02019; layers (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>, highlighted in red). Re-analysis of published SARS and MERS fusion cores reveals that &#x02018;x&#x02019; and &#x02018;da&#x02019; mode packing also exists in the 3HR1 cores of MER and SARS, albeit less prevalently than in &#x003b1;-HCoVs (HCoV-229E and HCoV-NL63) (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>). In the standard heptad repeats, although the &#x02018;a&#x02019; or &#x02018;d&#x02019; residues (knobs) interact around the trimer threefold axis, they do so in such a way that their side chains are more laterally arranged and fit in between the &#x02018;a&#x02019; and &#x02018;g&#x02019; residues (holes) or the &#x02018;d&#x02019; and &#x02018;e&#x02019; residues (holes), respectively (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>b</italic>, panels 1 and 2). In the noncanonical &#x02018;x&#x02019; layer, each packing residue points its side chain towards the centre of the threefold symmetry axis (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>b</italic>, third panel); while in the &#x02018;da&#x02019; layer the &#x02018;a&#x02019; and &#x02018;d&#x02019; packing residues are arranged in a pseudo-hexagonal manner through hydrophobic interactions, thereby leaving a large unfilled space in the middle (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>b</italic>, fourth panel). As a consequence, a central cavity is always seen in the &#x02018;da&#x02019; layer (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>; cavity shown as a yellow surface). As calculated with the <italic>CASTp</italic> 3.0 server (Dundas <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb10"> &#x025b8;</xref>), the molecular surface volume distribution of these cavities varies in different HCoVs. For HCoV-229E, the largest cavity seen in the Ala815/Ile816 &#x02018;da&#x02019; layer has a volume of 228&#x02005;&#x000c5;<sup>3</sup>, while the volumes of the cavities in the other &#x02018;da&#x02019; layers all fall between 20 and 50&#x02005;&#x000c5;<sup>3</sup>; for HCoV-NL63, the largest cavity was in the Ala996/Ile997 &#x02018;da&#x02019; layer, with a volume of 206&#x02005;&#x000c5;<sup>3</sup>, and the other cavities in &#x02018;da&#x02019; layers are all smaller than 55&#x02005;&#x000c5;<sup>3</sup>; for MERS, the largest cavity in the Asn1029/Ala1030 &#x02018;d/a&#x02019; layer has a volume of 266&#x02005;&#x000c5;<sup>3</sup> and no other cavity larger than 50&#x02005;&#x000c5;<sup>3</sup> was present in the structure. In sharp contrast to HCoV-229E, HCoV-NL63 and MERS, the cavities seen in the three &#x02018;da&#x02019; layers of the SARS 3HR1 core are all large, with volumes of 105, 232 and 285&#x02005;&#x000c5;<sup>3</sup>, respectively.</p><p>The presence of multiple large cavities (&#x0003e;100&#x02005;&#x000c5;<sup>3</sup>) in the middle of the 3HR1 core of SARS may suggest that the supercoils of SARS are less stable compared with the supercoils of HCoV-229E and HCoV-NL63. We thus calculated the average pitch values of different HCoVs using <italic>TWISTER</italic> (Strelkov &#x00026; Burkhard, 2002<xref ref-type="bibr" rid="bb50"> &#x025b8;</xref>). The pitch values of the HCoV-229E, HCoV-NL63 and MERS supercoils are 188.0, 189.3 and 187.2&#x02005;&#x000c5;, respectively, which are all similar to each other and close to the most commonly seen pitch of trimeric coiled-coil structures (Seo &#x00026; Cohen, 1993<xref ref-type="bibr" rid="bb48"> &#x025b8;</xref>). Nevertheless, the 194.7&#x02005;&#x000c5; pitch value of the SARS supercoil is longer than those of MERS, HCoV-229E and HCoV-NL63, indicating that the 3HR1 core of SARS is less twisted compared with the others.</p><p>Side-by-side electrostatic surface comparisons also reveal substantial differences between &#x003b1;-HCoVs and &#x003b2;-HCoVs (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>c</italic>). The electrostatic surface of SARS and MERS are strikingly similar to each other, except for some differences in the lower region (boxed with black dashed lines in Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>c</italic>). The electrostatic surfaces of HCoV-229E and HCoV-NL63 are also alike to some extent, but the 3HR1 core of HCoV-229E is more hydrophobic. In fact, the 3HR1 core of HCoV-229E seems to be the most hydrophobic among the four HCoVs. It is worth noting that at certain positions the electrostatic surface potentials are opposite in &#x003b1;-HCoVs and &#x003b2;-HCoVs (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>c</italic>; boxed with red dashed lines). Considering that both hydrophobic and electrostatic inter&#x000ad;actions between HR1 and HR2 contribute to the affinity between them (Aydin <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb2"> &#x025b8;</xref>), such differences in electrostatic surface potentials should be taken into consideration for the design and development of a pan-CoV inhibitory HR2 mimic.</p></sec><sec id="sec3.3"><label>3.3.</label><title>Interaction between HR1 and HR2 of HCoV-229E &#x000a0; </title><p>The HR2 residues 1067&#x02013;1097 of HCoV-229E fold into a nine-turn amphipathic &#x003b1;-helix (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>b</italic>), which fits snugly onto the 3HR1 core mainly through extensive hydrophobic inter&#x000ad;actions (Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>
<italic>a</italic>). Specifically, residues at the &#x02018;d&#x02019; position (Leu1067, Leu1074, Leu1081, Leu1088 and Ile1095) in this nine-turn &#x003b1;-helix bury their side chains (Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>
<italic>a</italic>; shown as orange stick models) into hydrophobic pockets on the surface of the 3HR1 core of HCoV-229E. Another kind of hydrophobic packing was also observed at locations where the hydrophobic surface on the 3HR1 core is relatively flat (Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>
<italic>a</italic>; hereafter termed ridges). At these locations, residues at the &#x02018;a&#x02019; (Ile1071, Ser1078, Val1085, Ile1092 and Leu1099) and &#x02018;g&#x02019; (Glu1070, Lys1077, Thr1084, Leu1091 and Thr1098) positions on the HR2 helix pack about 50% of the solvent-accessible surface area (SASA) of their side chains (Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>
<italic>a</italic>; shown as yellow stick models) against the HR1 residues constituting these ridges. Besides the nine-turn &#x003b1;-helix, the rest of HR2 adopts an extended conformation which also makes substantial hydrophobic inter&#x000ad;actions with the 3HR1 core. Interestingly, only the first type of hydrophobic inter&#x000ad;action was seen in these regions (Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>
<italic>a</italic>), where the side chains of Pro1053, Leu1055, Val1057, Tyr1060, Leu1065, Val1100, Leu1102 and Trp1104 (orange stick models in Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>
<italic>a</italic>) are completely buried in the cavities on the 3HR1 core. Overall, the side chains of hydrophobic residues from the HR2 helix of HCoV-229E fit tightly into the cavities and ridges on the 3HR1 core, almost like chains onto a sprocket (Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>
<italic>b</italic>). It is worth noting that the HR2 residues that either fill the hydrophobic cavities or mask the hydrophobic ridges on the 3HR1 core are largely conserved across the different HCoVs (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>g</italic>; denoted by stars and filled squares, respectively), corroborating the essential role played by hydrophobic inter&#x000ad;actions in the inter&#x000ad;action between HR1 and HR2.</p><p>Besides hydrophobic packing, electrostatic and polar inter&#x000ad;actions also contribute to the affinity and specificity between HR1 and HR2 (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>). In the helical region, residues on HR2 mainly engage residues on HR1 through side-chain to side-chain inter&#x000ad;actions that include hydrogen bonds and salt bridges (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>
<italic>a</italic>). In the extended region of HR2, extensive polar inter&#x000ad;actions were observed between the main-chain atoms on HR2 and the side chains of residues from HR1 (Figs. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>
<italic>b</italic> and 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>
<italic>c</italic>). It is worth noting that some of these interactions are highly conserved across different HCoVs (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>; conserved inter&#x000ad;actions are shown as yellow stick models, with black dashed lines indicating hydrogen bonds or salt bridges). Interestingly, these conserved inter&#x000ad;actions are mainly located in the regions adjacent to the end of the nine-turn helix, suggesting that they might play a critical role in fixing the register of the HR2 helical region on the HR1 surface.</p></sec></sec><sec id="sec4"><label>4.</label><title>Discussion &#x000a0; </title><p>We have determined the fusion-core structure of HCoV-229E at 1.86&#x02005;&#x000c5; resolution, thus further completing the structural profiles of HCoV fusion cores. The HCoV-229E structure reveals that its HR1 folds into an unusually long 24-turn helix, which is the longest observed so far in published HCoV fusion-core structures (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>). Currently, multiple fusion-core structures are available for SARS and MERS and each has a different HR1/HR2 coverage (or completeness) (Supekar <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb51"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>; Xu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb59"> &#x025b8;</xref>; Duquerroy <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb11"> &#x025b8;</xref>; Gao <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb16"> &#x025b8;</xref>). Among them, the most complete post-fusion structures are for SARS (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1wyy">1wyy</ext-link>; Duquerroy <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb11"> &#x025b8;</xref>) and MERS (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=4njl">4njl</ext-link>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>), with a21-turn and 22-turn HR1 helix, respectively (Figs. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>f</italic> and 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>). Both of these HR1s are shorter than the 24-turn HR1 reported here, as the HR1 helices of &#x003b1;-HCoVs are intrinsically longer than those of &#x003b2;-HCoVs owing to a 14-residue insertion in their HR1 domains (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>f</italic>). The 14-turn and 13-turn HR1 helices seen in previous post-fusion structures of HCoV-NL63 and HCoV-229E cover only around 56% of their annotated HR1 sequences (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>f</italic>; coverage highlighted with a yellow background; amino acids 981&#x02013;1031 <italic>versus</italic> 964&#x02013;1054 for HCoV-NL63 and amino acids 788&#x02013;838 <italic>versus</italic> 783&#x02013;873 for HCoV-229E; Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>; Zhang <italic>et al.</italic>, 2018<xref ref-type="bibr" rid="bb66"> &#x025b8;</xref>). In contrast, for the structure presented here the HR1 coverage is 97% (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>f</italic>; coverage highlighted with a cyan background; amino acids 785&#x02013;872 <italic>versus</italic> 783&#x02013;873), which represents the most complete post-fusion conformation among all published &#x003b1;-HCoV fusion-core structures (Figs. 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>f</italic> and 1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>
<italic>g</italic>).</p><p>Owing to the 14-residue insertion in the HR1 regions, the HR2 regions of &#x003b1;-HCoVs are also intrinsically longer than those of &#x003b2;-HCoVs. The HR2 helix of HCoV-229E consists of nine turns (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>), whereas in &#x003b2;-HCoVs such as MERS and SARS the HR2 helix is usually only 4&#x02013;5 turns (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>). As a functional outcome, the melting temperatures (<italic>T</italic>
<sub>m</sub>) of &#x003b1;-HCoVs are significantly and consistently higher than those of &#x003b2;-HCoVs, presumably owing to a larger buried interface and a higher affinity between the longer HR2s and 3HR1 cores of &#x003b1;-HCoVs. In detail, the <italic>T</italic>
<sub>m</sub> values for the HCoV-229E and HCoV-NL63 post-fusion cores are 90.1 and 98.0&#x000b0;C, respectively (Xia <italic>et al.</italic>, 2018<xref ref-type="bibr" rid="bb70"> &#x025b8;</xref>; Zheng <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb67"> &#x025b8;</xref>), while the <italic>T</italic>
<sub>m</sub> values for SARS and MERS are 85.0 and 87.0&#x000b0;C, respectively (Xu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb59"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>).</p><p>The fusion-core structure of HCoV-229E and those of SARS, MERS and HCoV-NL63 are similar to each other overall (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic>), despite differences in the packing of their 3HR1 cores. Specifically, &#x003b1;-HCoVs seem to have more non&#x000ad;canonical &#x02018;x&#x02019; and &#x02018;da&#x02019; layers than &#x003b2;-HCoVs, especially in the region of the 14-residue insertion (Figs. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>a</italic> and 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>b</italic>). Compared with the 3HR1 cores of MERS, HCoV-NL63 and HCoV-229E, the SARS supercoils are less twisted, as shown by the longer pitch and larger hydrophobic voids in the middle of the 3HR1 core. Moreover, side-by-side electrostatic surface comparisons of the 3HR1 cores also reveal substantial differences between &#x003b1;-HCoVs and &#x003b2;-HCoVs (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>c</italic>). Notably, at certain positions, the electrostatic surface potentials are opposite in &#x003b1;-HCoVs and &#x003b2;-HCoVs (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>
<italic>c</italic>).</p><p>Similar to other HCoVs, the high-affinity interaction between HR1 and HR2 of HCoV-229E is mediated by both extensive hydrophobic and hydrophilic interactions (Figs. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref> and 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>). Besides the highly conserved hydrophobic interactions, some polar and electrostatic interactions are also well preserved across different HCoVs (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>). Together, these conserved interactions and the differences in the electrostatic surface potential of 3HR1 cores across different HCoVs should be taken into consideration when designing pan-CoV inhibitors that mimic HR2 for targeting HR1. Although previous studies have found that peptides derived from the HR2s of SARS or MERS can prevent the host entry of the corresponding viruses, these peptides lack cross-inhibitory activity with each other or with other HCoVs (Liu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb33"> &#x025b8;</xref>; Lu <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>). Since most of the hydrophobic interactions between HR1 and HR2 are highly conserved across all HCoVs, this implies that hydrophilic interactions are also important for the adhesion and register of HR2s onto the 3HR1 cores. Indeed, it has been reported that both hydrophobic and hydrophilic interactions between HR1 and HR2 of SARS contribute to the affinity between them (Aydin <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb2"> &#x025b8;</xref>). Hence, a good pan-CoV inhibitory peptide mimic of HR2 would preserve all of the conserved hydrophobic and hydrophilic interactions between HR1 and HR2 of all HCoVs and also accommodate the variation among different HCoVs. More specifically, at the positions where the electrostatic surface potentials of 3HR1 cores are opposite in &#x003b1;-HCoVs and &#x003b2;-HCoVs, residues on the HR2 inhibitory peptide mimic should be carefully chosen such that they could form contacts, but not electrostatic or steric clashes, with surrounding residues on the 3HR1 cores of different HCoVs.</p><p>The deadly global outbreaks of SARS in 2002 and MERS in 2012 highlight the importance of developing vaccines or treatments for CoVs, for which there are still no effective drugs or vaccines available. Both SARS and MERS are zoonotic CoVs. Before inter-species jumping, humans rarely came into contact with zoonotic CoVs, and therefore lack neutralizing antibodies to zoonotic CoVs. As a consequence, zoonotic CoVs usually pose substantial health and pandemic threats to humans. Given the high genomic mutation rate of CoVs and ever-increasing global population shifts, future outbreaks of CoV pandemics such as SARS or MERS are very likely to occur. To this end, structural and functional characterization of HCoVs takes on greater significance, especially for the structure-based design of future therapies or vaccines.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="5yl9">HCoV-229E fusion core, 5yl9</ext-link>
</p></supplementary-material></sec></body><back><ack><p>We thank the staff of the BL17U1 beamline at the Shanghai Synchrotron Radiation Facility for assistance during data collection.</p></ack><ref-list><title>References</title><ref id="bb1"><mixed-citation publication-type="other">Adams, P. D. <italic>et al.</italic> (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 213&#x02013;221.</mixed-citation></ref><ref id="bb2"><mixed-citation publication-type="other">Aydin, H., Al-Khooly, D. &#x00026; Lee, J. E. (2014). <italic>Protein Sci.</italic>
<bold>23</bold>, 603&#x02013;617.</mixed-citation></ref><ref id="bb3"><mixed-citation publication-type="other">Baquero, E., Albertini, A. A., Vachette, P., Lepault, J., Bressanelli, S. &#x00026; Gaudin, Y. (2013). <italic>Curr. Opin. Virol.</italic>
<bold>3</bold>, 143&#x02013;150.</mixed-citation></ref><ref id="bb4"><mixed-citation publication-type="other">Belouzard, S., Chu, V. C. &#x00026; Whittaker, G. R. (2009). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>106</bold>, 5871&#x02013;5876.</mixed-citation></ref><ref id="bb5"><mixed-citation publication-type="other">Belouzard, S., Millet, J. K., Licitra, B. N. &#x00026; Whittaker, G. R. (2012). <italic>Viruses</italic>, <bold>4</bold>, 1011&#x02013;1033.</mixed-citation></ref><ref id="bb6"><mixed-citation publication-type="other">Bosch, B. J., Martina, B. E., van der Zee, R., Lepault, J., Haijema, B. J., Versluis, C., Heck, A. J., de Groot, R., Osterhaus, A. D. &#x00026; Rottier, P. J. (2004). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>101</bold>, 8455&#x02013;8460.</mixed-citation></ref><ref id="bb7"><mixed-citation publication-type="other">Channappanavar, R., Lu, L., Xia, S., Du, L., Meyerholz, D. K., Perlman, S. &#x00026; Jiang, S. (2015). <italic>J. Infect. Dis.</italic>
<bold>212</bold>, 1894&#x02013;1903.</mixed-citation></ref><ref id="bb8"><mixed-citation publication-type="other">Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. &#x00026; Richardson, D. C. (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 12&#x02013;21.</mixed-citation></ref><ref id="bb9"><mixed-citation publication-type="other">Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. &#x00026; Baker, N. A. (2004). <italic>Nucleic Acids Res.</italic>
<bold>32</bold>, W665&#x02013;W667.</mixed-citation></ref><ref id="bb10"><mixed-citation publication-type="other">Dundas, J., Ouyang, Z., Tseng, J., Binkowski, A., Turpaz, Y. &#x00026; Liang, J. (2006). <italic>Nucleic Acids Res.</italic>
<bold>34</bold>, W116&#x02013;W118.</mixed-citation></ref><ref id="bb11"><mixed-citation publication-type="other">Duquerroy, S., Vigouroux, A., Rottier, P. J. M., Rey, F. A. &#x00026; Bosch, B. J. (2005). <italic>Virology</italic>, <bold>335</bold>, 276&#x02013;285.</mixed-citation></ref><ref id="bb12"><mixed-citation publication-type="other">Emsley, P., Lohkamp, B., Scott, W. G. &#x00026; Cowtan, K. (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 486&#x02013;501.</mixed-citation></ref><ref id="bb13"><mixed-citation publication-type="other">Enjuanes, L., Almaz&#x000e1;n, F., Sola, I. &#x00026; Zu&#x000f1;iga, S. (2006). <italic>Annu. Rev. Microbiol.</italic>
<bold>60</bold>, 211&#x02013;230.</mixed-citation></ref><ref id="bb14"><mixed-citation publication-type="other">Forgie, S. &#x00026; Marrie, T. J. (2009). <italic>Semin. Respir. Crit. Care Med.</italic>
<bold>30</bold>, 67&#x02013;85.</mixed-citation></ref><ref id="bb15"><mixed-citation publication-type="other">Forni, D., Cagliani, R., Clerici, M. &#x00026; Sironi, M. (2017). <italic>Trends Microbiol.</italic>
<bold>25</bold>, 35&#x02013;48.</mixed-citation></ref><ref id="bb16"><mixed-citation publication-type="other">Gao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y., Geng, H., Li, H., Wang, Q., Xiao, H., Tan, W., Yan, J. &#x00026; Gao, G. F. (2013). <italic>J. Virol.</italic>
<bold>87</bold>, 13134&#x02013;13140.</mixed-citation></ref><ref id="bb17"><mixed-citation publication-type="other">Ge, X.-Y. <italic>et al.</italic> (2013). <italic>Nature (London)</italic>, <bold>503</bold>, 535&#x02013;538.</mixed-citation></ref><ref id="bb18"><mixed-citation publication-type="other">Greenberg, S. B. (2016). <italic>Semin. Respir. Crit. Care Med.</italic>
<bold>37</bold>, 555&#x02013;571.</mixed-citation></ref><ref id="bb19"><mixed-citation publication-type="other">Groot, R. J. de <italic>et al.</italic> (2013). <italic>J. Virol.</italic>
<bold>87</bold>, 7790&#x02013;7792.</mixed-citation></ref><ref id="bb20"><mixed-citation publication-type="other">Gui, M., Song, W., Zhou, H., Xu, J., Chen, S., Xiang, Y. &#x00026; Wang, X. (2017). <italic>Cell Res.</italic>
<bold>27</bold>, 119&#x02013;129.</mixed-citation></ref><ref id="bb21"><mixed-citation publication-type="other">Hamre, D. &#x00026; Procknow, J. J. (1966). <italic>Proc. Soc. Exp. Biol. Med.</italic>
<bold>121</bold>, 190&#x02013;193.</mixed-citation></ref><ref id="bb22"><mixed-citation publication-type="other">Han, D. P., Penn-Nicholson, A. &#x00026; Cho, M. W. (2006). <italic>Virology</italic>, <bold>350</bold>, 15&#x02013;25.</mixed-citation></ref><ref id="bb23"><mixed-citation publication-type="other">Heald-Sargent, T. &#x00026; Gallagher, T. (2012). <italic>Viruses</italic>, <bold>4</bold>, 557&#x02013;580.</mixed-citation></ref><ref id="bb24"><mixed-citation publication-type="other">Hoek, L. van der (2007). <italic>Antivir. Ther.</italic>
<bold>12</bold>, 651&#x02013;658.</mixed-citation></ref><ref id="bb25"><mixed-citation publication-type="other">Hu, H. <italic>et al.</italic> (2005). <italic>J. Comb. Chem.</italic>
<bold>7</bold>, 648&#x02013;656.</mixed-citation></ref><ref id="bb26"><mixed-citation publication-type="other">Hulswit, R. J., de Haan, C. A. &#x00026; Bosch, B. J. (2016). <italic>Adv. Virus Res.</italic>
<bold>96</bold>, 29&#x02013;57.</mixed-citation></ref><ref id="bb27"><mixed-citation publication-type="other">Jartti, L., Langen, H., S&#x000f6;derlund-Venermo, M., Vuorinen, T., Ruuskanen, O. &#x00026; Jartti, T. (2011). <italic>Open Respir. Med. J.</italic>
<bold>5</bold>, 61&#x02013;69.</mixed-citation></ref><ref id="bb28"><mixed-citation publication-type="other">Julien, J.-P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., Ward, A. B. &#x00026; Wilson, I. A. (2013). <italic>Science</italic>, <bold>342</bold>, 1477&#x02013;1483.</mixed-citation></ref><ref id="bb29"><mixed-citation publication-type="other">Kirchdoerfer, R. N., Cottrell, C. A., Wang, N., Pallesen, J., Yassine, H. M., Turner, H. L., Corbett, K. S., Graham, B. S., McLellan, J. S. &#x00026; Ward, A. B. (2016). <italic>Nature (London)</italic>, <bold>531</bold>, 118&#x02013;121.</mixed-citation></ref><ref id="bb30"><mixed-citation publication-type="other">Ksiazek, T. G. <italic>et al.</italic> (2003). <italic>N. Engl. J. Med.</italic>
<bold>348</bold>, 1953&#x02013;1966.</mixed-citation></ref><ref id="bb32"><mixed-citation publication-type="other">Li, F. (2016). <italic>Annu. Rev. Virol.</italic>
<bold>3</bold>, 237&#x02013;261.</mixed-citation></ref><ref id="bb33"><mixed-citation publication-type="other">Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C. R., Xiong, H., Farmar, J., Debnath, A. K., Tien, P. &#x00026; Jiang, S. (2004). <italic>Lancet</italic>, <bold>363</bold>, 938&#x02013;947.</mixed-citation></ref><ref id="bb34"><mixed-citation publication-type="other">Lu, L., Liu, Q., Zhu, Y., Chan, K.-H., Qin, L., Li, Y., Wang, Q., Chan, J. F.-W., Du, L., Yu, F., Ma, C., Ye, S., Yuen, K.-Y., Zhang, R. &#x00026; Jiang, S. (2014). <italic>Nature Commun.</italic>
<bold>5</bold>, 3067.</mixed-citation></ref><ref id="bb35"><mixed-citation publication-type="other">Lu, L., Xia, S., Ying, T. &#x00026; Jiang, S. (2015). <italic>Microbes Infect.</italic>
<bold>4</bold>, e37.</mixed-citation></ref><ref id="bb36"><mixed-citation publication-type="other">Lyumkis, D., Julien, J.-P., de Val, N., Cupo, A., Potter, C. S., Klasse, P. J., Burton, D. R., Sanders, R. W., Moore, J. P., Carragher, B., Wilson, I. A. &#x00026; Ward, A. B. (2013). <italic>Science</italic>, <bold>342</bold>, 1484&#x02013;1490.</mixed-citation></ref><ref id="bb37"><mixed-citation publication-type="other">Marra, M. A. <italic>et al.</italic> (2003). <italic>Science</italic>, <bold>300</bold>, 1399&#x02013;1404.</mixed-citation></ref><ref id="bb38"><mixed-citation publication-type="other">Matsuyama, S. &#x00026; Taguchi, F. (2002). <italic>J. Virol.</italic>
<bold>76</bold>, 11819&#x02013;11826.</mixed-citation></ref><ref id="bb39"><mixed-citation publication-type="other">Menachery, V. D., Yount, B. L., Debbink, K., Agnihothram, S. S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X.-Y., Donaldson, E. F., Randell, S. H., Lanzavecchia, A., Marasco, W. A., Shi, Z.-L. &#x00026; Baric, R. S. (2015). <italic>Nature Med.</italic>
<bold>21</bold>, 1508&#x02013;1513.</mixed-citation></ref><ref id="bb40"><mixed-citation publication-type="other">Menachery, V. D. <italic>et al.</italic> (2016). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>113</bold>, 3048&#x02013;3053.</mixed-citation></ref><ref id="bb41"><mixed-citation publication-type="other">Millet, J. K. &#x00026; Whittaker, G. R. (2014). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>111</bold>, 15214&#x02013;15219.</mixed-citation></ref><ref id="bb42"><mixed-citation publication-type="other">Millet, J. K. &#x00026; Whittaker, G. R. (2015). <italic>Virus Res.</italic>
<bold>202</bold>, 120&#x02013;134.</mixed-citation></ref><ref id="bb43"><mixed-citation publication-type="other">Park, J. E., Li, K., Barlan, A., Fehr, A. R., Perlman, S., McCray, P. B. Jr &#x00026; Gallagher, T. (2016). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>113</bold>, 12262&#x02013;12267.</mixed-citation></ref><ref id="bb44"><mixed-citation publication-type="other">Peiris, J. S. M.. Lai, S. T. <italic>et al.</italic> (2003). <italic>Lancet</italic>, <bold>361</bold>, 1319&#x02013;1325.</mixed-citation></ref><ref id="bb45"><mixed-citation publication-type="other">Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E. &#x00026; St&#x000f6;hr, K. (2003). <italic>N. Engl. J. Med.</italic>
<bold>349</bold>, 2431&#x02013;2441.</mixed-citation></ref><ref id="bb46"><mixed-citation publication-type="other">Perlman, S. &#x00026; Netland, J. (2009). <italic>Nature Rev. Microbiol.</italic>
<bold>7</bold>, 439&#x02013;450.</mixed-citation></ref><ref id="bb47"><mixed-citation publication-type="other">Rota, P. A. <italic>et al.</italic> (2003). <italic>Science</italic>, <bold>300</bold>, 1394&#x02013;1399.</mixed-citation></ref><ref id="bb48"><mixed-citation publication-type="other">Seo, J. &#x00026; Cohen, C. (1993). <italic>Proteins</italic>, <bold>15</bold>, 223&#x02013;234.</mixed-citation></ref><ref id="bb49"><mixed-citation publication-type="other">Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H. D. &#x00026; Rappuoli, R. (2003). <italic>Nature Rev. Microbiol.</italic>
<bold>1</bold>, 209&#x02013;218.</mixed-citation></ref><ref id="bb50"><mixed-citation publication-type="other">Strelkov, S. V. &#x00026; Burkhard, P. (2002). <italic>J. Struct. Biol.</italic>
<bold>137</bold>, 54&#x02013;64.</mixed-citation></ref><ref id="bb51"><mixed-citation publication-type="other">Supekar, V. M., Bruckmann, C., Ingallinella, P., Bianchi, E., Pessi, A. &#x00026; Carf&#x000ed;, A. (2004). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>101</bold>, 17958&#x02013;17963.</mixed-citation></ref><ref id="bb52"><mixed-citation publication-type="other">Walls, A. C., Tortorici, M. A., Bosch, B. J., Frenz, B., Rottier, P. J. M., DiMaio, F., Rey, F. A. &#x00026; Veesler, D. (2016). <italic>Nature (London)</italic>, <bold>531</bold>, 114&#x02013;117.</mixed-citation></ref><ref id="bb53"><mixed-citation publication-type="other">Walls, A. C., Tortorici, M. A., Frenz, B., Snijder, J., Li, W., Rey, F. A., DiMaio, F., Bosch, B. J. &#x00026; Veesler, D. (2016). <italic>Nature Struct. Mol. Biol.</italic>
<bold>23</bold>, 899&#x02013;905.</mixed-citation></ref><ref id="bb55"><mixed-citation publication-type="other">Wilde, A. H. de, Snijder, E. J., Kikkert, M. &#x00026; van Hemert, M. J. (2017). <italic>Curr. Top. Microbiol. Immunol.</italic>, https://doi.org/10.1007/82_2017_25.</mixed-citation></ref><ref id="bb56"><mixed-citation publication-type="other">Wilson, I. A., Skehel, J. J. &#x00026; Wiley, D. C. (1981). <italic>Nature (London)</italic>, <bold>289</bold>, 366&#x02013;373.</mixed-citation></ref><ref id="bb57"><mixed-citation publication-type="other">Wong, A. H. M., Tomlinson, A. C. A., Zhou, D., Satkunarajah, M., Chen, K., Sharon, C., Desforges, M., Talbot, P. J. &#x00026; Rini, J. M. (2017). <italic>Nature Commun.</italic>
<bold>8</bold>, 1735.</mixed-citation></ref><ref id="bb58"><mixed-citation publication-type="other">Woo, P. C., Lau, S. K., Huang, Y. &#x00026; Yuen, K. Y. (2009). <italic>Exp. Biol. Med. (Maywood)</italic>, <bold>234</bold>, 1117&#x02013;1127.</mixed-citation></ref><ref id="bb54"><mixed-citation publication-type="other">World Health Organization (2016). <italic>WHO MERS-CoV Global Summary and Risk Assessment</italic>. Geneva: World Health Organization.</mixed-citation></ref><ref id="bb70"><mixed-citation publication-type="other">Xia, S., Xu, W., Wang, Q., Wang, C., Hua, C., Li, W., Lu, L. &#x00026; Jiang, S. (2018). <italic>Int. J. Mol. Sci.</italic>
<bold>19</bold>, 487.</mixed-citation></ref><ref id="bb59"><mixed-citation publication-type="other">Xu, Y., Lou, Z., Liu, Y., Pang, H., Tien, P., Gao, G. F. &#x00026; Rao, Z. (2004). <italic>J. Biol. Chem.</italic>
<bold>279</bold>, 49414&#x02013;49419.</mixed-citation></ref><ref id="bb60"><mixed-citation publication-type="other">Yao, H., Lee, M., Liao, S.-Y. &#x00026; Hong, M. (2016). <italic>Biochemistry</italic>, <bold>55</bold>, 6787&#x02013;6800.</mixed-citation></ref><ref id="bb61"><mixed-citation publication-type="other">Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T. &#x00026; Holmes, K. V. (1992). <italic>Nature (London)</italic>, <bold>357</bold>, 420&#x02013;422.</mixed-citation></ref><ref id="bb62"><mixed-citation publication-type="other">Yi, L. <italic>et al.</italic> (2004). <italic>J. Virol.</italic>
<bold>78</bold>, 11334&#x02013;11339.</mixed-citation></ref><ref id="bb63"><mixed-citation publication-type="other">Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., Lu, G., Wu, Y., Yan, J., Shi, Y., Zhang, X. &#x00026; Gao, G. F. (2017). <italic>Nature Commun.</italic>
<bold>8</bold>, 15092.</mixed-citation></ref><ref id="bb64"><mixed-citation publication-type="other">Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. &#x00026; Fouchier, R. A. (2012). <italic>N. Engl. J. Med.</italic>
<bold>367</bold>, 1814&#x02013;1820.</mixed-citation></ref><ref id="bb65"><mixed-citation publication-type="other">Zelus, B. D., Schickli, J. H., Blau, D. M., Weiss, S. R. &#x00026; Holmes, K. V. (2003). <italic>J. Virol.</italic>
<bold>77</bold>, 830&#x02013;840.</mixed-citation></ref><ref id="bb66"><mixed-citation publication-type="other">Zhang, W., Zheng, Q., Yan, M., Chen, X., Yang, H., Zhou, W. &#x00026; Rao, Z. (2018). <italic>Biochem. Biophys. Res. Commun.</italic>
<bold>497</bold>, 705&#x02013;712.</mixed-citation></ref><ref id="bb67"><mixed-citation publication-type="other">Zheng, Q., Deng, Y., Liu, J., van der Hoek, L., Berkhout, B. &#x00026; Lu, M. (2006). <italic>Biochemistry</italic>, <bold>45</bold>, 15205&#x02013;15215.</mixed-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Overall structure of the HCoV-229E fusion core. (<italic>a</italic>) Schematic diagram illustrating the design of the HR1-L6-HR2 fusion-core construct. (<italic>b</italic>, <italic>c</italic>) Monomeric (<italic>b</italic>) and trimeric (<italic>c</italic>) structures of the HR1-L6-HR2 fusion protein. The red pole (left panel) and filled triangle (right panel) in (<italic>c</italic>) represent the trimer threefold axis. (<italic>d</italic>) The packing of HR2 against the central hydrophobic core of HR1 as illustrated by a solvent-accessible surface rendering. The solvent-accessible surface is coloured according to the electrostatic potential, which ranges from +5&#x02005;V (most positive, dark blue) to &#x02212;5&#x02005;V (most negative, dark red), with hydrophobic in white. (<italic>e</italic>) The HR2 helices are depicted as dark grey ribbons on the light grey surface of the HCoV-229E 3HR1 core to highlight the corresponding insertions in HR1 and HR2 in red and yellow, respectively. (<italic>f</italic>, <italic>g</italic>) Sequence alignment of the HR1 region (<italic>f</italic>) and HR2 region (<italic>g</italic>) of HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, SARS and MERS. The HR1 and HR2 coverages of previous HCoV structures (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=2ieq">2ieq</ext-link> for HCoV-NL63, PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1wyy">1wyy</ext-link> for SARS and PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=4njl">4njl</ext-link> for MERS) and the recently reported HCoV-229E structure (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=5zhy">5zhy</ext-link>; Zhang <italic>et al.</italic>, 2018<xref ref-type="bibr" rid="bb66"> &#x025b8;</xref>) are depicted with a yellow background. The HCoV-229E structure presented here is denoted with a cyan highlight. The filled squares and stars underneath the residues highlight the conservation of residues in HR2 that are involved in hydrophobic interactions between HR1 and HR2 in the various HCoVs.</p></caption><graphic xlink:href="d-74-00841-fig1"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Differences in the 3HR1 core between &#x003b1;-HCoVs and &#x003b2;-HCoVs. (<italic>a</italic>) A side-by-side comparison illustrates the differences in the heptad-repeat packing geometry of HCoV-229E, HCoV-NL63 (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=2ieq">2ieq</ext-link>), SARS (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1wyy">1wyy</ext-link>) and MERS (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=4njl">4njl</ext-link>). The hydrophobic 3HR1 core is depicted as a grey ribbon, cavities as a yellow surface mesh and the side chains of residues at &#x02018;d/a&#x02019; positions as cyan stick models. The helical turns are numbered from the N-terminus to the C-terminus on one of the HR1 helices in the trimer. On the left of each ribbon representation, the packing residues lining the trimeric coiled-coil interface are indicated in black, with residues at the &#x02018;a&#x02019; and &#x02018;d&#x02019; positions (canonical &#x02018;a&#x02019; and &#x02018;d&#x02019; layer) boxed in beige, residues at &#x02018;x&#x02019; positions (&#x02018;x&#x02019; layer) in magenta and residues at &#x02018;d/a&#x02019; positions (&#x02018;da&#x02019; layer) in cyan. (<italic>b</italic>) From left to right: cross-sections of representative &#x02018;a&#x02019;, &#x02018;d&#x02019;, &#x02018;x&#x02019; and &#x02018;da&#x02019; layers in the 3HR1 core of HCoV-229E. The 2<italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> electron-density maps are contoured at 2&#x003c3;. (<italic>c</italic>) Electrostatic surfaces illustrating differences in the 3HR1 core from HCoV-229E, HCoV-NL63, SARS and MERS. The red dashed boxes depict the regions on different 3HR1 cores where the electrostatic surface potentials are opposite in &#x003b1;-HCoVs and &#x003b2;-HCoVs. The black dashed boxes highlight the only regions on SARS and MERS where the electrostatic surface potentials are different.</p></caption><graphic xlink:href="d-74-00841-fig2"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Two types of hydrophobic interactions are observed between the HR1 and HR2 helices. (<italic>a</italic>) Left panel: electrostatic surface illustrating the hydrophobic cavities on the surface of the HCoV-229E 3HR1 core. The lower half of the 3HR1 core is rotated for better display of the hydrophobic cavities in this region. Right panel: HR2 helices are shown as teal ribbons on the dark grey surface of the HCoV-229E 3HR1 core. HR2 residues that bury their side chains completely into the cavities on HR1 are shown as orange stick models and HR2 residues that pack around 50% of the solvent-accessible surface of their side chains on ridges of HR1 are depicted as yellow stick models. (<italic>b</italic>) Surface representation of HR1 and HR2 helices illustrating that HR2 residues fit snugly onto the surface of the 3HR1 core, thereby filling hydrophobic cavities in HR1 and masking its hydrophobic surface. The 3HR1 core is shown as an electrostatic surface, and HR2 residues involved in hydrophobic interactions are depicted as orange (completely buried) and yellow (packing, &#x0223c;50% buried) surfaces, respectively.</p></caption><graphic xlink:href="d-74-00841-fig3"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Comparison of different CoV fusion cores reveals differences and similarities in the interactions between their HR1 and HR2 motifs. Cartoon representations illustrating the side-chain electrostatic and polar interactions (<italic>a</italic>) and main-chain polar interactions (<italic>b</italic>, <italic>c</italic>) between HR1 and HR2 in HCoV-229E, HCoV-NL63 (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=2ieq">2ieq</ext-link>), SARS (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1wyy">1wyy</ext-link>) and MERS (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=4njl">4njl</ext-link>). Interactions between HR1 residues and the main-chain atoms of HR2 are only seen in the N-terminal (<italic>c</italic>) and C-terminal (<italic>b</italic>) extended regions of HR2. The HR1 motifs are depicted as white ribbons and the HR2 motifs as green ribbons. For clarity, only two HR1 motifs of the 3HR1 core are shown. The HR1 and the HR2 residues that are involved in interactions are illustrated as stick models, with black dashed lines representing hydrogen bonds and/or salt bridges. The residues are colour-coded as follows: HR1, whitish grey; HR2, teal (HCoV-229E), hot pink (HCoV-NL63), gold (MERS) and slate (SARS). Interactions that are conserved across different HCoVs are shown as yellow stick models. All polar interactions of HCoV-229E are clearly labelled, whereas only conserved interactions are labelled for the other HCoVs. The labels of HR1 residues are differentiated from those of HR2 residues by a prime after the residue number.</p></caption><graphic xlink:href="d-74-00841-fig4"/></fig><table-wrap id="table1" orientation="portrait" position="float"><label>Table 1</label><caption><title>X-ray data-collection and refinement statistics</title><p>Values in parentheses are for the outer shell.</p></caption><table frame="hsides" rules="groups"><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">Space group</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>32:<italic>H</italic>
</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">
<italic>a</italic>, <italic>b</italic>, <italic>c</italic> (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">46.9, 46.9, 402.1</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x003b1;, &#x003b2;, &#x003b3; (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 120</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Wavelength (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">0.9795</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Resolution range (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">44.7&#x02013;1.86 (1.93&#x02013;1.86)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">No. of unique reflections</td><td rowspan="1" colspan="1" align="left" valign="top">15101 (1465)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Completeness (%)</td><td rowspan="1" colspan="1" align="left" valign="top">99.9 (100)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Multiplicity</td><td rowspan="1" colspan="1" align="left" valign="top">20.9 (21.6)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02329;<italic>I</italic>/&#x003c3;(<italic>I</italic>)&#x0232a;</td><td rowspan="1" colspan="1" align="left" valign="top">31.5 (5.3)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>
<sub>meas</sub>
<xref ref-type="table-fn" rid="tfn1">&#x02020;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">7.5 (67.0)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>
<sub>p.i.m.</sub>
<xref ref-type="table-fn" rid="tfn2">&#x02021;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">1.6 (14.3)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">CC<sub>1/2</sub>
<xref ref-type="table-fn" rid="tfn3">&#x000a7;</xref>
</td><td rowspan="1" colspan="1" align="left" valign="top">0.964</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Overall Wilson <italic>B</italic> value (&#x000c5;<sup>2</sup>)</td><td rowspan="1" colspan="1" align="left" valign="top">24</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">No. of reflections (work)</td><td rowspan="1" colspan="1" align="left" valign="top">14231 (1379)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">No. of reflections (test)</td><td rowspan="1" colspan="1" align="left" valign="top">764 (86)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>
<sub>cryst</sub>
<xref ref-type="table-fn" rid="tfn4">&#x000b6;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">18.4 (22.0)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>
<sub>free</sub>
<xref ref-type="table-fn" rid="tfn4">&#x000b6;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">20.6 (25.5)</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">No. of non-H atoms</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">1117</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Water</td><td rowspan="1" colspan="1" align="left" valign="top">115</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">R.m.s. deviations</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Bonds (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">0.008</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Angles (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">1.00</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">Average <italic>B</italic> values (&#x000c5;<sup>2</sup>)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">30</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Water</td><td rowspan="1" colspan="1" align="left" valign="top">43</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">Ramachandran plot</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Most favoured (%)</td><td rowspan="1" colspan="1" align="left" valign="top">99.29</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Allowed (%)</td><td rowspan="1" colspan="1" align="left" valign="top">0.71</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>&#x02020;</label><p>
<italic>R</italic>
<sub>meas</sub> = <inline-formula><inline-graphic xlink:href="d-74-00841-efi1.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>
<inline-formula><inline-graphic xlink:href="d-74-00841-efi2.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>.</p></fn><fn id="tfn2"><label>&#x02021;</label><p>
<italic>R</italic>
<sub>p.i.m.</sub> = <inline-formula><inline-graphic xlink:href="d-74-00841-efi3.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>
<inline-formula><inline-graphic xlink:href="d-74-00841-efi2.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>.</p></fn><fn id="tfn3"><label>&#x000a7;</label><p>CC<sub>1/2</sub> is the Pearson correlation coefficient between two random half data sets for the outer shell.</p></fn><fn id="tfn4"><label>&#x000b6;</label><p>
<italic>R</italic>
<sub>meas</sub> = <inline-formula><inline-graphic xlink:href="d-74-00841-efi5.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>
<inline-formula><inline-graphic xlink:href="d-74-00841-efi6.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>; <italic>R</italic>
<sub>free</sub> is defined as <italic>R</italic>
<sub>cryst</sub> calculated from 5% of reflections that were excluded during refinement.</p></fn></table-wrap-foot></table-wrap></floats-group></article>